Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
7.54
-0.04 (-0.46%)
Jan 22, 2025, 2:03 PM EST - Market open
Astria Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$25.60
Upside
+239.75%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +112.34% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Dec 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +112.34% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +112.34% | Nov 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $26 → $28 | Buy | Maintains | $26 → $28 | +271.60% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +112.34% | Sep 27, 2024 |
| Wedbush | Wedbush | Buy Reiterates $22 | Buy | Reiterates | $22 | +191.97% | Aug 13, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $25 → $26 | Buy | Maintains | $25 → $26 | +245.06% | Aug 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +112.34% | Aug 13, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +364.50% | Jul 29, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $29 → $25 | Buy | Maintains | $29 → $25 | +231.79% | May 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +112.34% | May 10, 2024 |
| Wedbush | Wedbush | Buy Reiterates $22 | Buy | Reiterates | $22 | +191.97% | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $16 | Strong Buy | Maintains | $18 → $16 | +112.34% | Apr 23, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $25 → $29 | Buy | Maintains | $25 → $29 | +284.87% | Mar 26, 2024 |
| Wedbush | Wedbush | Buy Maintains $17 | Buy | Maintains | $17 | +125.61% | Mar 26, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.